Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|28|5051-5064

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.28, 2013-04, pp. : 5051-5064

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 187-206

Bentham Science Publishers

Access to resources Recommend Favorite

Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders

By  

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1923-1929

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin and Cognitive Function in Neurodegenerative Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 34-46

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1513-1529

Bentham Science Publishers

Access to resources Recommend Favorite